FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma Dahkki Pierre-Yves Salaun, Thomas Gastinne, Eric Frampas, Caroline Bodet-Milin, Philippe Moreau, Françoise Bodéré-Kraeber

Viečča ollesdeavstta

Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14) Dahkki Cyrille Touzeau, Steven Le Gouill, Béatrice Mahé, Jean Samuel Boudreault, Thomas Gastinne, Nicolas Blin, Hélène Caillon, Christelle Dousset, Martine Amiot, Philippe Moreau

Viečča ollesdeavstta

Surgical treatment of a foscavir-resistant atypical Cytomegalovirus pneumonia in an allogeneic stem cell transplant recipient Dahkki C. Bressollette-Bodin, A. Claver, D. Boutolleau, P. Chevallier, T. Guillaume, T. Gastinne, P. Moreau, J-L. Harousseau, B.M. Imbert-Marcille, S. Le Gouill

Viečča ollesdeavstta

18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin’s disease Dahkki Catherine Ansquer, Thomas Hervouët, Anne Devillers, Sophie de Guibert, Thomas Gastinne, Steven Le Gouill, Etienne Garin, Anne Moreau, Françoise Kraeber-Bodéré, Thierry Lamy

Viečča ollesdeavstta

Immune-related adverse events with bispecific T-cell engager therapy targeting B-cell maturation antigen Dahkki Bénédicte Piron, Mathilde Bastien, Chloé Antier, Romain Dalla-Torre, Bastien Jamet, Thomas Gastinne, Viviane Dubruille, Philippe Moreau, Jérôme Martin, Antoine Bénichou, Cyrille Touzeau, Benoît Tessoulin

Viečča ollesdeavstta

Features and outcomes of patients admitted to the ICU for chimeric antigen receptor T cell-related toxicity: a French multicentre cohort Dahkki Corentin Le Cacheux, Audrey Couturier, Clara Sortais, Roch Houot, Morgane Péré, Thomas Gastinne, Amélie Seguin, Jean Reignier, Jean-Baptiste Lascarrou, Jean-Marc Tadié, Quentin Quelven, Emmanuel Canet

Viečča ollesdeavstta

Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin’s lymphoma by 18F-fluorodeoxyglucose positron emission tomography Dahkki Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Benoît Dupas, Franck Morschhauser, Thomas Gastinne, Steven Le Gouill, Loïc Campion, Jean-Luc Harousseau, William A. Wegener, David M. Goldenberg, Damien Huglo

Viečča ollesdeavstta

The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement Dahkki Steven Le Gouill, Pascaline Talmant, Cyrille Touzeau, Anne Moreau, Richard Garand, Nadine Juge-Morineau, Fanny Gaillard, Thomas Gastinne, Noël Milpied, Philippe Moreau, Jean Luc Harousseau, Hervé Avet-Loiseau

Viečča ollesdeavstta

Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma Dahkki Louise Bouard, Benoit Tessoulin, Catherine Thieblemont, Kamal Bouabdallah, Thomas Gastinne, Lucie Oberic, Sylvain Carras, Caroline Delette, Olivier Casasnovas, Caroline Dartigeas, Victoria Cacheux, Sibylle Masse, Olivier Hermine, Steven Le Gouill

Viečča ollesdeavstta

P1090: LONG TERM FOLLOW-UP OF UNTREATED/RELAPSING MCL PATIENTS WITH THE IBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX COMBINATION. Dahkki Steven Le Gouill, Franck Morschhauser, David Chiron, Kamal Bouabdallah, Guillaume Cartron, Rene Olivier Casasnovas, Caroline Milin, Charles Herbaux, Emmanuelle Tchernonog, Cedric Rossi, Simon Rule, Thomas Gastinne, Mary Callanan, Benoit Tessoulin

Viečča ollesdeavstta

Classical Hodgkin’s lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant Dahkki Eric Van Den Neste, Olivier Casasnovas, Marc André, Mohamed Touati, Delphine Senecal, Véronique Edeline, Aspasia Stamatoullas, Luc Fornecker, Bénédicte Deau, Thomas Gastinne, Oumédaly Reman, Isabelle Gaillard, Cécile Borel, Pauline Brice, Christophe Fermé

Viečča ollesdeavstta

P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY. Dahkki Clementine Sarkozy, Catherine Thieblemont, Lucie Oberic, Anne Moreau, Kamal Bouabdallah, Gandhi Laurent Damaj, Thomas Gastinne, Vincent Ribrag, Rene Olivier Casasnovas, Corinne Haioun, Roch Houot, Fabrice Jardin, Eric Van Den Neste, Morgane Cheminant, Franck Morschhauser, Mary Callanan, Herve Ghesquieres, Remy Gressin, Olivier Hermine, Steven Le Gouill

Viečča ollesdeavstta

P1123: EARLY CTDNA CLEARANCE AFTER CAR T-CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B-CELL LYMPHOMA: RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY Dahkki Marie-Helene Delfau-Larue, Lucie Gomes, Guillaume Cartron, Franck Morschhauser, Francois-Xavier Gros, Thomas Gastinne, Lucie Oberic, Emmanuel Bachy, Pierre Feugier, Rémy Duléry, Cedric Menard, Celine Pangault, Alexis Claudel, Cathy Quelen, Cedric Portugues, Pierre-Julien Viailly, Francois Lemonnier, Emmanuel Itti, Clément Bailly, Camille Laurent, Roch Houot

Viečča ollesdeavstta

A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma Dahkki Eric Van Den Neste, Marc André, Thomas Gastinne, Aspasia Stamatoullas, Corinne Haioun, Amine Belhabri, Oumedaly Reman, Olivier Casasnovas, Hervé Ghesquieres, Gregor Verhoef, Marie-José Claessen, Hélène A. Poirel, Marie-Christine Copin, Romain Dubois, Peter Vandenberghe, Ioanna-Andrea Stoian, Anne S. Cottereau, Sarah Bailly, Laurent Knoops, Franck Morschhauser

Viečča ollesdeavstta

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transp... Dahkki Marie José Kersten, Julia Driessen, Josée M. Zijlstra, Wouter J. Plattel, Franck Morschhauser, Pieternella J. Lugtenburg, Pauline Brice, Martin Hutchings, Thomas Gastinne, Roberto Liu, Coreline N. Burggraaff, Marcel Nijland, Sanne H. Tonino, Anne I.J. Arens, Roelf Valkema, Harm van Tinteren, Marta Lopez-Yurda, Arjan Diepstra, Daphne De Jong, Anton Hagenbeek

Viečča ollesdeavstta

P1146: TRANSFUSION NEEDS AFTER CD19 CAR T-CELLS FOR LARGE B-CELL LYMPHOMA: PREDICTIVE FACTORS AND IMPACT ON OUTCOME. A DESCAR-T STUDY. Dahkki Samuel Vic, Jean-Baptiste Thibert, Emmanuel Bachy, Guillaume Cartron, Thomas Gastinne, Ibrahim Yakoub-Agha, Fabien Le Bras, Kamal Bouabdallah, Fabien Despas, Jacques Olivier Bay, Marie-Thérèse Rubio, Mohamad Mohty, Rene Olivier Casasnovas, Sylvain Choquet, Cristina Castilla-Llorente, Stephanie Guidez, Michael Loschi, Blandine Guffroy, Sylvain Carras, Laurianne Drieu La Rochelle, Roch Houot

Viečča ollesdeavstta

Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study Dahkki Julien Lazarovici, Peggy Dartigues, Pauline Brice, Lucie Obéric, Isabelle Gaillard, Mathilde Hunault-Berger, Florence Broussais-Guillaumot, Emmanuel Gyan, Serge Bologna, Emmanuelle Nicolas-Virelizier, Mohamed Touati, Olivier Casasnovas, Richard Delarue, Frédérique Orsini-Piocelle, Aspasia Stamatoullas, Jean Gabarre, Luc-Matthieu Fornecker, Thomas Gastinne, Fréderic Peyrade, Virginie Roland, Emmanuel Bachy, Marc André, Nicolas Mounier, Christophe Fermé

Viečča ollesdeavstta

FLT3 ligand plasma levels in acute myeloid leukemia Dahkki Pierre Peterlin, Joelle Gaschet, Thierry Guillaume, Alice Garnier, Marion Eveillard, Amandine Le Bourgeois, Michel Cherel, Camille Debord, Yannick Le Bris, Olivier Theisen, Béatrice Mahé, Viviane Dubruille, Catherine Godon, Nelly Robillard, Soraya Wuilleme, Cyrille Touzeau, Thomas Gastinne, Nicolas Blin, Anne Lok, Antoine Bonnet, Steven Le Gouill, Philippe Moreau, Marie-C Béné, Patrice Chevallier

Viečča ollesdeavstta

S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LARGE B-CELL LYMPHOMA IN TRANSPLANT-INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY Dahkki Roch Houot, Emmanuel Bachy, Guillaume Cartron, Francois-Xavier Gros, Franck Morschhauser, Lucie Oberic, Thomas Gastinne, Pierre Feugier, Rémy Duléry, Catherine Thieblemont, Magalie Joris, Fabrice Jardin, Sylvain Choquet, Rene Olivier Casasnovas, Gabriel Brisou, Morgane Cheminant, Jacques Olivier Bay, Francisco Llamas, Cedric Menard, Karin Tarte, Marie-Helene Delfau-Larue, Emmanuel Itti, Clément Bailly, Yassine Al Tabaa, Camille Laurent, Francois Lemonnier

Viečča ollesdeavstta

Outcomes of patients with relapsed or refractory primary mediastinal B‐cell lymphoma treated with anti‐CD19 CAR‐T cells: CARTHYM, a study from the French national DESCAR‐T registry... Dahkki Jean Galtier, Charles Mesguich, Pierre Sesques, Vivien Dupont, Emmanuel Bachy, Roberta Di Blasi, Catherine Thieblemont, Thomas Gastinne, Guillaume Cartron, Gabriel Brisou, François‐Xavier Gros, Justine Decroocq, Franck Morschhauser, Marie‐Thérèse Rubio, Laurianne Drieu La Rochelle, Fabien Le Bras, Sylvain Carras, Adrien Chauchet, Jacques‐Olivier Bay, Magalie Joris, Mickael Loschi, Aline Tanguy‐Schmidt, Alexandra Marquet, Vincent Camus, Steven Le Gouill, Roch Houot, Krimo Bouabdallah

Viečča ollesdeavstta